Bristol Myers plans UK launch of schizophrenia drug Cobenfy, matching US price – Reuters

  1. Bristol Myers plans UK launch of schizophrenia drug Cobenfy, matching US price  Reuters
  2. UK under pressure as BMS sets US-level price for schizophrenia drug  Financial Times
  3. Bristol Myers plans UK launch of schizophrenia drug in 2026  The Mighty 790 KFGO
  4. Bristol Myers Squibb Aligns Schizophrenia Drug Pricing in UK and US  MSN

Continue Reading